| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $112 ) |
| | 2025 | 2023 | LIFORDI IMMUNOTHERAPEUTICS, INC. | 1 VAN DE GRAAFF DR | BURLINGTON | MA | 01803-5188 | MIDDLESEX | USA | R44AI165119 | Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases | 001 | 4 | NIH | 1/21/2025 | $112 |
|
| Issue Date FY: 2024 ( Subtotal = $993,646 ) |
| | 2024 | 2023 | LIFORDI IMMUNOTHERAPEUTICS, INC. | C/O 5AM VENTURES 200 CLARENDON STREET, 22ND FLOOR | BOSTON | MA | 02116 | SUFFOLK | USA | R44AI165119 | Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases | 001 | 4 | NIH | 6/25/2024 | $993,646 |
|
|
